Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use INCRUSE ELLIPTA safely and effectively. See full prescribing information for INCRUSE ELLIPTA.INCRUSE ELLIPTA (umeclidinium inhalation powder), for oral inhalation useInitial U.S. Approval: 2013
Medication labelWhy this: Advisory · dailymed-prescription
INCRUSE ELLIPTA is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
- generic_name
- umeclidinium
- product_names
- umeclidinium
- ndc
- 0173-0873, 0173-0873-10, 0173-0873-06
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en